共 192 条
- [1] Ueno NT(1997)Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M.D. Anderson Cancer Center Cancer Chemother Pharmacol 40 321-9
- [2] Buzdar AU(2014)Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes Ann Oncol 25 384-91
- [3] Singletary SE(2013)Survival differences between patients with metastatic inflammatory and non-inflammatory breast cancer Cancer Res 73 Abstract nr P6-12-02-8
- [4] Ames FC(2003)Update on the management of inflammatory breast cancer Oncologist 8 141-44
- [5] McNeese MD(2007)Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease Cancer 110 1436-75
- [6] Holmes FA(2010)Inflammatory breast cancer: the disease, the biology, the treatment CA Cancer J Clin 60 351-9
- [7] Masuda H(2000)Molecular biology of breast cancer metastasis: inflammatory breast cancer: clinical syndrome and molecular determinants Breast Cancer Res 2 423-71
- [8] Brewer TM(2004)Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification Clin Cancer Res 10 7965-103
- [9] Liu DD(2004)High incidence of HER2 positivity in inflammatory breast cancer Breast 13 97-7
- [10] Iwamoto T(2004)Prognostic value of p53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma Cancer 101 913-8